Cargando…
The future of bronchodilation: looking for new classes of bronchodilators
Available bronchodilators can satisfy many of the needs of patients suffering from airway disorders, but they often do not relieve symptoms and their long-term use raises safety concerns. Therefore, there is interest in developing new classes that could help to overcome the limits that characterise...
Autores principales: | Cazzola, Mario, Rogliani, Paola, Matera, Maria Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488694/ https://www.ncbi.nlm.nih.gov/pubmed/31871127 http://dx.doi.org/10.1183/16000617.0095-2019 |
Ejemplares similares
-
Beyond Dual Bronchodilation – Triple Therapy, When and Why
por: Cazzola, Mario, et al.
Publicado: (2022) -
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019) -
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
por: Rogliani, Paola, et al.
Publicado: (2017) -
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
por: Matera, Maria Gabriella, et al.
Publicado: (2015) -
Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation
por: Maniscalco, Mauro, et al.
Publicado: (2021)